Kinnate Biopharma Inc
F:6KB
Kinnate Biopharma Inc
F:6KB
Price:
2.42
EUR
Market Closed
Market Cap:
€114m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kinnate Biopharma Inc
F:6KB
|
US |
|
I
|
InterCure Ltd
TASE:INCR
|
IL |
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
K
|
KGHM Polska Miedz SA
OTC:KGHPF
|
PL |
|
Willamette Valley Vineyards Inc
NASDAQ:WVVI
|
US |
|
Derluks Yatirim Holding AS
IST:DERHL.E
|
TR |
|
T
|
Talant Optronics suzhou Co Ltd
SZSE:301045
|
CN |
|
A
|
Asiamet Resources Ltd
OTC:KMGLF
|
CA |
|
City Union Bank Ltd
BSE:532210
|
IN |
|
J
|
JBDI Holdings Ltd
NASDAQ:JBDI
|
SG |
|
Kyung Dong Navien Co Ltd
KRX:009450
|
KR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 6KB.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6KB
Multiples-Based Value
Not Available
Multiples Across Competitors
6KB Competitors Multiples
Kinnate Biopharma Inc Competitors
Kinnate Biopharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Kinnate Biopharma Inc
F:6KB
|
114m EUR | 0 | -1.2 | 0.2 | 0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.6B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.8B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.2B AUD | 3 | 32.8 | 11 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
